A global healthcare company successfully navigated the complex APAC vaccine landscape by developing a robust framework for policy intelligence and market access. By leveraging well-connected local consultants and regional experts, the firm gained critical insights into vaccine policy, stakeholder attitudes, and procurement processes. The implementation of a regional dashboard provided leadership with real-time analysis, enabling the company to effectively influence policy and mitigate commercial risks in key Asia-Pacific markets.

‍

Following the approval of its COVID-19 vaccine in 2022, a healthcare company was transformed overnight. This created an immediate need to gain visibility into global vaccine policy and procurement processes. The company established in-house teams in top markets while engaging consultancies for support in other regions, particularly in the Asia Pacific. The primary challenge was to receive early warnings and analysis on policy issues, understand stakeholder attitudes, identify pathways to market, and monitor competitors and reputational risks.

‍

‍

Our strategy involved deploying well-connected local consultants in each country to engage in direct conversations with relevant stakeholders. The intelligence and insights gathered by these local teams were then fed to regional experts. These experts were responsible for collating and contextualizing the information for regional and global management, ensuring a comprehensive understanding of the landscape.

An APAC regional dashboard was created to display trending issues and opportunities, providing a high-level overview for leadership. This system enabled management to "double-click" into the details of key issues, offering clear insights into their status, expected developments, and potential commercial impact. Ultimately, this enhanced the company's ability to effectively engage with and influence key policy and procurement matters.